{{Rsnum
|rsid=969088
|Chromosome=5
|position=26389153
|Orientation=minus
|GMAF=0.168
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 93.8 | 6.2 | 0.0
| HCB | 50.4 | 40.9 | 8.8
| JPT | 46.0 | 48.7 | 5.3
| YRI | 52.4 | 38.1 | 9.5
| ASW | 70.2 | 26.3 | 3.5
| CHB | 50.4 | 40.9 | 8.8
| CHD | 59.6 | 33.0 | 7.3
| GIH | 95.0 | 5.0 | 0.0
| LWK | 50.9 | 40.9 | 8.2
| MEX | 67.2 | 29.3 | 3.4
| MKK | 71.0 | 27.7 | 1.3
| TSI | 93.1 | 6.9 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22872573
  |Trait=Response to platinum-based chemotherapy in non-small-cell lung cancer
  |Title=Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy.
  |RiskAllele=C
  |Pval=3E-6
  |OR=1.40
  |ORtxt=[1.22-1.61]
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}